175 related articles for article (PubMed ID: 15725048)
1. Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study.
Swanson RN; Lainez-Ventosilla A; De Salvo MC; Dunne MW; Amsden GW
Treat Respir Med; 2005; 4(1):31-9. PubMed ID: 15725048
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
3. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
Nalepa P; Dobryniewska M; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Notario G; Spiller J; Palmer R; Busman T
Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
[TBL] [Abstract][Full Text] [Related]
5. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
[TBL] [Abstract][Full Text] [Related]
6. Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis.
Kaiser L; Morabia A; Stalder H; Ricchetti A; Auckenthaler R; Terrier F; Hirschel B; Khaw N; Lacroix JS; Lew D
Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):445-51. PubMed ID: 11561799
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
Sethi S; Breton J; Wynne B
Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
9. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
Martinez FJ; Grossman RF; Zadeikis N; Fisher AC; Walker K; Ambruzs ME; Tennenberg AM
Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
[TBL] [Abstract][Full Text] [Related]
10. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group.
Anzueto A; Niederman MS; Tillotson GS
Clin Ther; 1998; 20(5):885-900. PubMed ID: 9829441
[TBL] [Abstract][Full Text] [Related]
11. Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
Fogarty C; de Wet R; Mandell L; Chang J; Rangaraju M; Nusrat R
Chest; 2005 Oct; 128(4):1980-8. PubMed ID: 16236845
[TBL] [Abstract][Full Text] [Related]
12. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis.
Adler JL; Jannetti W; Schneider D; Zhang J; Palmer R; Notario G
Clin Ther; 2000 Dec; 22(12):1410-20. PubMed ID: 11192133
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis.
Ziering W; McElvaine P
Infection; 1998; 26(1):68-75. PubMed ID: 9505188
[TBL] [Abstract][Full Text] [Related]
14. Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.
Niederman MS; Anzueto A; Sethi S; Choudhri S; Kureishi A; Haverstock D; Perroncel R
Respir Med; 2006 Oct; 100(10):1781-90. PubMed ID: 16531032
[TBL] [Abstract][Full Text] [Related]
15. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
Wilson R; Schentag JJ; Ball P; Mandell L;
Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408
[TBL] [Abstract][Full Text] [Related]
16. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
DeAbate CA; Henry D; Bensch G; Jubran A; Chodosh S; Harper L; Tipping D; Talbot GH
Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
[TBL] [Abstract][Full Text] [Related]
17. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Busman TA; Norris S; Notario GF
Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
19. Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis.
McCarty JM; Pierce PF
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):327-34. PubMed ID: 11686426
[TBL] [Abstract][Full Text] [Related]
20. A randomized, multicenter, double blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media.
Arguedas A; Emparanza P; Schwartz RH; Soley C; Guevara S; de Caprariis PJ; Espinoza G
Pediatr Infect Dis J; 2005 Feb; 24(2):153-61. PubMed ID: 15702045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]